Literature DB >> 2813260

A pharmacokinetic model of intravenously administered hyaluronan in sheep.

L Lebel1, J R Fraser, W S Kimpton, J Gabrielsson, B Gerdin, T C Laurent.   

Abstract

Hyaluronan (HA: hyaluronic acid) is produced in the interstitium and reaches the blood circulation through the lymph. It is rapidly eliminated by means of specific receptors on liver endothelium. The elimination characteristics of intravenously administered HA were studied in 10 conscious sheep at the normal plasma HA concentration by injection of a 3H-labeled tracer and at a very high concentration by an i.v. infusion of unlabeled HA and simultaneous injection of a tracer dose of 3H-labeled HA. At a normal plasma HA concentration (0.12 +/- 0.05 microgram/ml; range, 0.072-0.228 microgram/ml), the apparent T 1/2 of 3H-HA was 5.3 +/- 1.1 min (range, 3.3-6.5 min). At higher plasma concentrations (range, 1.83-3.35 micrograms/ml), the apparent T 1/2 was considerably prolonged (range, 18.2-43.5 min). A one-compartment, nonlinear model was fitted to data obtained from the bolus-infusion study of unlabeled HA. The Michaelis-Menten constant, Km, was 0.12 +/- 0.04 microgram/ml, indicating that a deviation from linear kinetics will occur when the normal plasma concentration is exceeded. The Vmax was 0.062 +/- 0.009 microgram/ml/min. Three-dimensional surface plots showed that the plasma HA concentration and the total hepatic plasma flow influence the apparent metabolic clearance, extraction ratio, turnover, and T 1/2 of intravenously injected hyaluronan. There was a high correlation between T 1/2 as measured by the injected 3H-HA and T 1/2 calculated from the model (r = 0.96).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2813260     DOI: 10.1023/a:1015982204926

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy.

Authors:  A Engström-Laurent; R Hällgren
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103

2.  Serum hyaluronate in primary biliary cirrhosis--a biochemical marker for progressive liver damage.

Authors:  A Nyberg; A Engström-Laurent; L Lööf
Journal:  Hepatology       Date:  1988 Jan-Feb       Impact factor: 17.425

3.  Distribution of biologically labelled radioactive hyaluronic acid injected into joints.

Authors:  K N Antonas; J R Fraser; K D Muirden
Journal:  Ann Rheum Dis       Date:  1973-03       Impact factor: 19.103

4.  A sheep preparation for studying interactions between blood flow and drug disposition. I: Physiological profile.

Authors:  W B Runciman; A H Ilsley; L E Mather; R Carapetis; M M Rao
Journal:  Br J Anaesth       Date:  1984-09       Impact factor: 9.166

5.  Concentration of sodium hyaluronate in serum.

Authors:  A Engström-Laurent; U B Laurent; K Lilja; T C Laurent
Journal:  Scand J Clin Lab Invest       Date:  1985-10       Impact factor: 1.713

6.  Removal of hyaluronic acid from the circulation in rheumatoid disease and primary biliary cirrhosis.

Authors:  J R Fraser; A Engström-Laurent; A Nyberg; T C Laurent
Journal:  J Lab Clin Med       Date:  1986-01

7.  Elevated levels of plasma hyaluronan in septicaemia.

Authors:  S Berg; B Brodin; F Hesselvik; T C Laurent; R Maller
Journal:  Scand J Clin Lab Invest       Date:  1988-12       Impact factor: 1.713

8.  Circulating hyaluronate: concentration in different vascular beds in man.

Authors:  K D Bentsen; J H Henriksen; T C Laurent
Journal:  Clin Sci (Lond)       Date:  1986-08       Impact factor: 6.124

9.  Concentration and relative molecular mass of hyaluronate in lymph and blood.

Authors:  A Tengblad; U B Laurent; K Lilja; R N Cahill; A Engström-Laurent; J R Fraser; H E Hansson; T C Laurent
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

10.  The catabolic fate of hyaluronic acid.

Authors:  T C Laurent; I M Dahl; L B Dahl; A Engström-Laurent; S Eriksson; J R Fraser; K A Granath; C Laurent; U B Laurent; K Lilja
Journal:  Connect Tissue Res       Date:  1986       Impact factor: 3.417

View more
  5 in total

Review 1.  Scavenger functions of the liver endothelial cell.

Authors:  B Smedsrød; H Pertoft; S Gustafson; T C Laurent
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

2.  Biocompatible blood pool MRI contrast agents based on hyaluronan.

Authors:  Wenlian Zhu; Dmitri Artemov
Journal:  Contrast Media Mol Imaging       Date:  2010-10-28       Impact factor: 3.161

3.  Serum hyaluronate in patients with acute and fulminant hepatitis.

Authors:  K Suzuki; R Endo; Y Takikawa; I Nakadate; S Sato
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

4.  Effect of a Particulate and a Putty-Like Tricalcium Phosphate-Based Bone-grafting Material on Bone Formation, Volume Stability and Osteogenic Marker Expression after Bilateral Sinus Floor Augmentation in Humans.

Authors:  Christine Knabe; Doaa Adel-Khattab; Esther Kluk; Rainer Struck; Michael Stiller
Journal:  J Funct Biomater       Date:  2017-07-29

5.  Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes.

Authors:  Hussaini Syed Sha Qhattal; Tanvirul Hye; Amer Alali; Xinli Liu
Journal:  ACS Nano       Date:  2014-05-15       Impact factor: 15.881

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.